Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

Early Communication Intervention for Toddlers With Hearing Loss

Phase 2

Active, not recruiting

Conditions: Hearing Loss, Bilateral

Interventions: Other: No Intervention - Business-as-usual control
Behavioral: Parent-Implemented Communication Intervention (PICT)

First Posted Date: 2019-01-15

Last Posted Date: 2024-11-15

Lead Sponsor: Northwestern University

Target Recruit Count: 96

Registration Number: NCT03803943

Locations: 🇺🇸
Northwestern University, Evanston, Illinois, United States

Expressive Helping for Stem Cell Transplant Patients

Phase 3

Completed

Conditions: Hematologic Malignancy
Stem Cell Transplantation

Interventions: Behavioral: Expressive Helping
Behavioral: Factual Writing

First Posted Date: 2019-01-11

Last Posted Date: 2023-05-06

Lead Sponsor: Northwestern University

Target Recruit Count: 405

Registration Number: NCT03800758

Locations: 🇺🇸
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes

Phase 4

Terminated

Conditions: Hot Flashes
Prostate Cancer

Interventions: Drug: .5% Bupivacaine

First Posted Date: 2019-01-08

Last Posted Date: 2023-01-25

Lead Sponsor: Northwestern University

Target Recruit Count: 1

Registration Number: NCT03796195

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment

Active, not recruiting

Conditions: Psoriasis

Interventions: Other: Fasting blood draw for lipid assessments

First Posted Date: 2019-01-02

Last Posted Date: 2024-03-13

Lead Sponsor: Northwestern University

Target Recruit Count: 62

Registration Number: NCT03791216

Locations: 🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

Maximizing Outcomes for Preschoolers With Developmental Language Disorders

Phase 2

Active, not recruiting

Conditions: Developmental Language Disorder

Interventions: Behavioral: the Enhanced Milieu Teaching-Sentence Focus

First Posted Date: 2018-12-20

Last Posted Date: 2024-10-15

Lead Sponsor: Northwestern University

Target Recruit Count: 108

Registration Number: NCT03782493

Locations: 🇺🇸
Northwestern University, Evanston, Illinois, United States
🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Wearable Skin Sensors to Assess Nocturnal Scratch Behavior

Completed

Conditions: Atopic Dermatitis

Interventions: Drug: Crisaborole
Device: Scratch sensor

First Posted Date: 2018-12-10

Last Posted Date: 2023-10-13

Lead Sponsor: Northwestern University

Target Recruit Count: 23

Registration Number: NCT03770858

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Genetic Analysis of Pediatric Psoriasis

Completed

Conditions: Psoriasis

Interventions: Other: Saliva or buccal sample

First Posted Date: 2018-12-07

Last Posted Date: 2022-04-20

Lead Sponsor: Northwestern University

Target Recruit Count: 86

Registration Number: NCT03768284

Locations: 🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

Redesigning Systems to Improve Quality for Hospitalized Patients

Not Applicable

Completed

Conditions: Adverse Event
Interdisciplinary Communication
Interpersonal Relations
Interprofessional Relations

Interventions: Behavioral: Advanced and Integrated MicroSystems (AIMS) interventions

First Posted Date: 2018-11-19

Last Posted Date: 2023-01-12

Lead Sponsor: Northwestern University

Target Recruit Count: 4265

Registration Number: NCT03745677

Locations: 🇺🇸
Alamance Regional Medical Center, Burlington, North Carolina, United States
🇺🇸
Baptist Hospital, Pensacola, Florida, United States
🇺🇸
Legacy Good Samaritan Hospital, Portland, Oregon, United States

and more 1 locations

Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease

Phase 3

Completed

Conditions: Peripheral Artery Disease

Interventions: Drug: Nicotinamide riboside
Drug: Resveratrol
Other: Placebo

First Posted Date: 2018-11-16

Last Posted Date: 2023-06-26

Lead Sponsor: Northwestern University

Target Recruit Count: 90

Registration Number: NCT03743636

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma

Phase 1

Conditions: Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
High Grade B-Cell Lymphoma, Not Otherwise Specified
Diffuse Large B-Cell Lymphoma
High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements

Interventions: Drug: Cyclophosphamide
Drug: Doxorubicin Hydrochloride
Drug: Prednisone
Biological: Rituximab
Drug: Spleen Tyrosine Kinase Inhibitor TAK-659
Drug: Vincristine Sulfate

First Posted Date: 2018-11-15

Last Posted Date: 2021-05-06

Lead Sponsor: Northwestern University

Target Recruit Count: 12

Registration Number: NCT03742258

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy